Nathaly P Llore1, Karina A Bruestle1, Adam Griesemer1,2. 1. Columbia Center for Translational Immunology, Columbia University College of Physicians and Surgeons. 2. Department of Surgery, Columbia University, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: The aim of this study was to review the recent progress in xenotransplantation achieved through genetic engineering and discuss the potential of tolerance induction to overcome remaining barriers to extended xenograft survival. RECENT FINDINGS: The success of life-saving allotransplantation has created a demand for organ transplantation that cannot be met by the supply of human organs. Xenotransplantation is one possible solution that would allow for a nearly unlimited supply of organs. Recent genetic engineering of swine has decreased the reactivity of preformed antibodies to some, but not all, potential human recipients. Experiments using genetically modified swine organs have now resulted in survival of life-supporting kidneys for over a year. However, the grafts show evidence of antibody-mediated rejection on histology, suggesting additional measures will be required for further extension of graft survival. Tolerance induction through mixed chimerism or thymic transplantation across xenogeneic barriers would be well suited for patients with a positive crossmatch to genetically modified swine or relatively negative crossmatches to genetically modified swine, respectively. SUMMARY: This review highlights the current understanding of the immunologic processes in xenotransplantation and describes the development and application of strategies designed to overcome them from the genetic modification of the source animal to the induction of tolerance to xenografts.
PURPOSE OF REVIEW: The aim of this study was to review the recent progress in xenotransplantation achieved through genetic engineering and discuss the potential of tolerance induction to overcome remaining barriers to extended xenograft survival. RECENT FINDINGS: The success of life-saving allotransplantation has created a demand for organ transplantation that cannot be met by the supply of human organs. Xenotransplantation is one possible solution that would allow for a nearly unlimited supply of organs. Recent genetic engineering of swine has decreased the reactivity of preformed antibodies to some, but not all, potential human recipients. Experiments using genetically modified swine organs have now resulted in survival of life-supporting kidneys for over a year. However, the grafts show evidence of antibody-mediated rejection on histology, suggesting additional measures will be required for further extension of graft survival. Tolerance induction through mixed chimerism or thymic transplantation across xenogeneic barriers would be well suited for patients with a positive crossmatch to genetically modified swine or relatively negative crossmatches to genetically modified swine, respectively. SUMMARY: This review highlights the current understanding of the immunologic processes in xenotransplantation and describes the development and application of strategies designed to overcome them from the genetic modification of the source animal to the induction of tolerance to xenografts.
Authors: Laura Higginbotham; Dave Mathews; Cynthia A Breeden; Mingqing Song; Alton Brad Farris; Christian P Larsen; Mandy L Ford; Andrew J Lutz; Matthew Tector; Kenneth A Newell; A Joseph Tector; Andrew B Adams Journal: Xenotransplantation Date: 2015-04-03 Impact factor: 3.907
Authors: Gregory R Martens; Luz M Reyes; Ping Li; James R Butler; Joseph M Ladowski; Jose L Estrada; Richard A Sidner; Devin E Eckhoff; Matt Tector; A Joseph Tector Journal: Transplantation Date: 2017-04 Impact factor: 4.939
Authors: L A Lee; H A Gritsch; J J Sergio; J S Arn; R M Glaser; T Sablinski; D H Sachs; M Sykes Journal: Proc Natl Acad Sci U S A Date: 1994-11-08 Impact factor: 11.205
Authors: Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares Journal: Science Date: 2002-12-19 Impact factor: 47.728
Authors: Raimon Duran-Struuck; Hugo P Sondermeijer; Leo Bühler; Paula Alonso-Guallart; Jonah Zitsman; Yojiro Kato; Anette Wu; Alicia N McMurchy; David Woodland; Adam Griesemer; Mercedes Martinez; Svetlan Boskovic; Tatsuo Kawai; A Benedict Cosimi; Yong-Guang Yang; Zheng Hu; Cheng-Shie Wuu; Andrea Slate; Markus Mapara; Sam Baker; Rafal Tokarz; Vivette D'Agati; Scott Hammer; Marcus Pereira; W Ian Lipkin; Thomas Wekerle; Megan Levings; Megan Sykes Journal: Transplantation Date: 2017-02 Impact factor: 4.939
Authors: Elizabeth E Waffarn; Mohsen Khosravi-Maharlooei; Andrea Vecchione; Steven Shao; Paresh Vishwasrao; Markus A HÖlzl; Kristjana Frangaj; Megan Sykes; Hao Wei Li Journal: Xenotransplantation Date: 2021-04-26 Impact factor: 3.788